V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196502 | 20152512 | 1.72 | 70 | Palliative (P) | 2021-01-14 | 2021-02-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100696647 |
| 20196503 | 20152513 | 1.61 | 70 | null | 2018-10-23 | 2018-11-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101277572 |
| 20196510 | 20152514 | 1.81 | 103 | null | 2016-11-08 | 2016-11-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101116603 |
| 20196511 | 20152515 | 1.55 | 58 | null | 2019-02-28 | 2019-02-28 | Docetaxel | 02 | N | DOCETAXEL | 100892528 |
| 20196515 | 20152516 | 1.66 | 59.15 | Palliative (P) | 2018-09-26 | 2018-12-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101063708 |
| 20196516 | 20152517 | 1.68 | 57 | Palliative (P) | 2016-11-12 | 2016-11-15 | Docetaxel | 02 | N | DOCETAXEL | 100242055 |
| 20196519 | 20152518 | 1.66 | 90.4 | Palliative (P) | 2019-06-12 | 2019-08-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100752596 |
| 20196524 | 20152519 | 1.85 | 84.4 | Palliative (P) | 2016-11-27 | 2016-11-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101163427 |
| 20196528 | 20152520 | 1.6 | 65.7 | null | 2020-02-13 | 2020-02-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101396547 |
| 20196542 | 20152521 | 1.85 | 7.2 | Palliative (P) | 2020-09-16 | 2020-10-01 | Docetaxel | 02 | N | DOCETAXEL | 100426991 |
| 20196544 | 20152522 | 1.76 | 90.6 | Palliative (P) | 2018-03-27 | 2018-11-04 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101762849 |
| 20196547 | 20152523 | 1.75 | 93.4 | Adjuvant (A) | 2022-01-07 | 2022-01-14 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101077014 |
| 20196553 | 20152524 | 1.83 | 63.5 | Palliative (P) | 2018-10-14 | 2018-11-27 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101008293 |
| 20196561 | 20152525 | null | null | Palliative (P) | 2017-11-19 | 2017-11-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100719370 |
| 20196566 | 20152526 | 1.67 | 83.3 | Palliative (P) | 2020-10-19 | 2020-11-05 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101318502 |
| 20196569 | 20152527 | 1.84 | 66.9 | Palliative (P) | 2013-05-11 | 2017-01-05 | Cetuximab + FOLFIRI cycle1 | 02 | null | CAPECITABINE + GEMCITABINE | 100120621 |
| 20196577 | 20152528 | 1.61 | 57.3 | Curative (C) | 2016-09-03 | 2016-09-04 | Cetuximab + FOLFIRI cycle1 | null | Y | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101012131 |
| 20196585 | 20152529 | 1.59 | 67.1 | null | 2020-11-03 | 2020-11-03 | Docetaxel | 02 | null | DOCETAXEL | 101453818 |
| 20196595 | 20152530 | 1.87 | 61 | null | 2021-12-30 | 2022-01-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100739912 |
| 20196598 | 20152531 | 1.7 | 83.9 | Palliative (P) | 2020-01-14 | 2020-01-15 | Docetaxel | 02 | N | CAPECITABINE + GEMCITABINE | 101181100 |
| 20196611 | 20152532 | 1.84 | 46.4 | null | 2020-10-08 | 2020-10-10 | Docetaxel | 02 | null | DOCETAXEL | 101205805 |
| 20196613 | 20152533 | 1.85 | 58.95 | null | 2017-09-21 | 2018-01-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100892417 |
| 20196614 | 20152534 | 1.61 | 56.5 | Adjuvant (A) | 2021-04-05 | 2021-04-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101521357 |
| 20196621 | 20152535 | 1.76 | 77.6 | Palliative (P) | 2017-11-14 | 2018-01-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100480977 |
| 20196624 | 20152536 | 1.52 | 72 | Palliative (P) | 2020-02-21 | 2020-02-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 101671993 |
| 20196630 | 20152537 | 1.61 | 74.3 | Palliative (P) | 2018-03-22 | 2018-03-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101853470 |
| 20196633 | 20152538 | 1.76 | 99.7 | null | 2020-02-20 | 2020-02-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100197357 |
| 20196641 | 20152539 | 1.7 | 74 | Palliative (P) | 2016-07-20 | 2016-07-23 | Docetaxel | 02 | N | DOCETAXEL | 101540856 |
| 20196650 | 20152540 | 0 | 62 | null | 2019-09-04 | 2019-09-08 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101096128 |
| 20196662 | 20152541 | 1.6 | null | Palliative (P) | 2016-09-17 | 2016-09-30 | Docetaxel | 02 | N | DOCETAXEL | 101520004 |
| 20196670 | 20152542 | 1.5 | 92.7 | Palliative (P) | 2019-03-08 | 2019-03-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101742018 |
| 20196671 | 20152543 | 1.61 | 86.5 | null | 2019-08-12 | 2019-08-12 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101501028 |
| 20196675 | 20152544 | 1.7 | 65 | Palliative (P) | 2018-05-12 | 2018-11-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101141329 |
| 20196679 | 20152545 | 1.59 | 92.6 | null | 2019-10-16 | 2019-11-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 100935827 |
| 20196681 | 20152546 | 1.83 | 91.3 | Palliative (P) | 2017-03-14 | 2017-03-17 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101667870 |
| 20196683 | 20152547 | 1.87 | 53.4 | Palliative (P) | 2018-11-04 | 2019-01-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101488493 |
| 20196687 | 20152548 | 1.84 | 104.1 | Palliative (P) | 2017-05-01 | 2017-05-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100414678 |
| 20196696 | 20152549 | 1.68 | 61.4 | Palliative (P) | 2018-01-17 | 2018-04-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100176835 |
| 20196699 | 20152550 | 1.88 | 88.3 | Palliative (P) | 2018-11-17 | 2018-12-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100555387 |
| 20196700 | 20152551 | 1.76 | 50 | Palliative (P) | 2020-03-28 | 2020-04-16 | Docetaxel | 02 | N | DOCETAXEL | 100380639 |
| 20196707 | 20152552 | 1.66 | 48.25 | Palliative (P) | 2020-05-31 | 2020-06-13 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100432562 |
| 20196717 | 20152553 | 1.76 | 80 | Palliative (P) | 2018-06-09 | 2018-06-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100897046 |
| 20196719 | 20152554 | 1.65 | 77.8 | Palliative (P) | 2021-09-17 | 2021-10-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101359250 |
| 20196722 | 20152555 | 1.53 | 53.2 | Palliative (P) | 2019-02-06 | 2019-02-22 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100197137 |
| 20196726 | 20152556 | 1.74 | 66.4 | null | null | null | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101744862 |
| 20196729 | 20152557 | 1.7 | 67 | Palliative (P) | 2018-09-29 | 2018-09-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101697044 |
| 20196735 | 20152558 | 1.7 | 57 | Palliative (P) | 2021-03-13 | 2021-03-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101015016 |
| 20196736 | 20152559 | 1.63 | 49.1 | Palliative (P) | 2020-09-20 | 2020-11-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101237654 |
| 20196738 | 20152560 | 1.7 | 38.7 | Palliative (P) | 2019-08-20 | 2019-09-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101090721 |
| 20196749 | 20152561 | 1.67 | 78 | Neo-adjuvant (N) | 2016-03-12 | 2016-03-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101825605 |